nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—TNF—Alzheimer's disease	0.338	1	CbGaD
Epinephrine—SLC22A2—Memantine—Alzheimer's disease	0.18	0.541	CbGbCtD
Epinephrine—CYP2C9—Donepezil—Alzheimer's disease	0.057	0.171	CbGbCtD
Epinephrine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0414	0.124	CbGbCtD
Epinephrine—CYP3A4—Donepezil—Alzheimer's disease	0.0331	0.0995	CbGbCtD
Epinephrine—CYP3A4—Galantamine—Alzheimer's disease	0.0213	0.0641	CbGbCtD
Epinephrine—Coldness—Donepezil—Alzheimer's disease	0.00952	0.0659	CcSEcCtD
Epinephrine—Feeling cold—Donepezil—Alzheimer's disease	0.00516	0.0357	CcSEcCtD
Epinephrine—Hemiplegia—Donepezil—Alzheimer's disease	0.00412	0.0285	CcSEcCtD
Epinephrine—Hemiplegia—Memantine—Alzheimer's disease	0.00375	0.0259	CcSEcCtD
Epinephrine—Supraventricular tachycardia—Galantamine—Alzheimer's disease	0.0029	0.0201	CcSEcCtD
Epinephrine—Cerebral haemorrhage—Donepezil—Alzheimer's disease	0.00266	0.0184	CcSEcCtD
Epinephrine—ADRBK1—embryo—Alzheimer's disease	0.00245	0.069	CbGeAlD
Epinephrine—Cerebral haemorrhage—Memantine—Alzheimer's disease	0.00242	0.0167	CcSEcCtD
Epinephrine—Myocardial ischaemia—Galantamine—Alzheimer's disease	0.00236	0.0164	CcSEcCtD
Epinephrine—Supraventricular tachycardia—Donepezil—Alzheimer's disease	0.00225	0.0156	CcSEcCtD
Epinephrine—ADRBK1—forebrain—Alzheimer's disease	0.00217	0.061	CbGeAlD
Epinephrine—Supraventricular tachycardia—Memantine—Alzheimer's disease	0.00204	0.0141	CcSEcCtD
Epinephrine—Supraventricular tachycardia—Rivastigmine—Alzheimer's disease	0.002	0.0138	CcSEcCtD
Epinephrine—ADRBK1—telencephalon—Alzheimer's disease	0.00199	0.0561	CbGeAlD
Epinephrine—Ventricular arrhythmia—Memantine—Alzheimer's disease	0.00181	0.0125	CcSEcCtD
Epinephrine—Necrosis—Memantine—Alzheimer's disease	0.0017	0.0118	CcSEcCtD
Epinephrine—Contusion—Donepezil—Alzheimer's disease	0.00169	0.0117	CcSEcCtD
Epinephrine—Ventricular extrasystoles—Donepezil—Alzheimer's disease	0.00163	0.0113	CcSEcCtD
Epinephrine—Myocardial ischaemia—Rivastigmine—Alzheimer's disease	0.00163	0.0113	CcSEcCtD
Epinephrine—Pallor—Memantine—Alzheimer's disease	0.00161	0.0112	CcSEcCtD
Epinephrine—Pallor—Rivastigmine—Alzheimer's disease	0.00158	0.0109	CcSEcCtD
Epinephrine—PAH—nervous system—Alzheimer's disease	0.00154	0.0434	CbGeAlD
Epinephrine—PAH—central nervous system—Alzheimer's disease	0.00149	0.0418	CbGeAlD
Epinephrine—Dipivefrin—ACHE—Alzheimer's disease	0.00148	0.365	CrCbGaD
Epinephrine—Renal impairment—Galantamine—Alzheimer's disease	0.00145	0.01	CcSEcCtD
Epinephrine—Cerebrovascular accident—Galantamine—Alzheimer's disease	0.00141	0.00974	CcSEcCtD
Epinephrine—Skin exfoliation—Memantine—Alzheimer's disease	0.00128	0.00883	CcSEcCtD
Epinephrine—Hypokalaemia—Galantamine—Alzheimer's disease	0.00126	0.00869	CcSEcCtD
Epinephrine—ADRA1D—forebrain—Alzheimer's disease	0.00125	0.0351	CbGeAlD
Epinephrine—Skin exfoliation—Rivastigmine—Alzheimer's disease	0.00125	0.00864	CcSEcCtD
Epinephrine—Pulmonary oedema—Memantine—Alzheimer's disease	0.00119	0.00824	CcSEcCtD
Epinephrine—PAH—brain—Alzheimer's disease	0.00118	0.0332	CbGeAlD
Epinephrine—ADRBK1—nervous system—Alzheimer's disease	0.00118	0.0331	CbGeAlD
Epinephrine—Pulmonary oedema—Rivastigmine—Alzheimer's disease	0.00116	0.00806	CcSEcCtD
Epinephrine—ADRA1D—telencephalon—Alzheimer's disease	0.00115	0.0323	CbGeAlD
Epinephrine—ADRBK1—central nervous system—Alzheimer's disease	0.00113	0.0319	CbGeAlD
Epinephrine—ADRBK1—cerebellum—Alzheimer's disease	0.00111	0.0312	CbGeAlD
Epinephrine—Hypoglycaemia—Donepezil—Alzheimer's disease	0.0011	0.00758	CcSEcCtD
Epinephrine—Cerebrovascular accident—Donepezil—Alzheimer's disease	0.00109	0.00755	CcSEcCtD
Epinephrine—Disorientation—Memantine—Alzheimer's disease	0.00109	0.00751	CcSEcCtD
Epinephrine—Hyperglycaemia—Galantamine—Alzheimer's disease	0.00108	0.00744	CcSEcCtD
Epinephrine—Renal failure—Galantamine—Alzheimer's disease	0.00105	0.00723	CcSEcCtD
Epinephrine—Psychotic disorder—Donepezil—Alzheimer's disease	0.00104	0.00722	CcSEcCtD
Epinephrine—Renal impairment—Memantine—Alzheimer's disease	0.00102	0.00706	CcSEcCtD
Epinephrine—Renal impairment—Rivastigmine—Alzheimer's disease	0.000998	0.0069	CcSEcCtD
Epinephrine—Hypoglycaemia—Memantine—Alzheimer's disease	0.000995	0.00688	CcSEcCtD
Epinephrine—Cerebrovascular accident—Memantine—Alzheimer's disease	0.000991	0.00685	CcSEcCtD
Epinephrine—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.000973	0.00673	CcSEcCtD
Epinephrine—Hypokalaemia—Donepezil—Alzheimer's disease	0.000973	0.00673	CcSEcCtD
Epinephrine—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.000969	0.00671	CcSEcCtD
Epinephrine—Haemoglobin—Galantamine—Alzheimer's disease	0.000959	0.00664	CcSEcCtD
Epinephrine—Haemorrhage—Galantamine—Alzheimer's disease	0.000955	0.0066	CcSEcCtD
Epinephrine—Hallucination—Galantamine—Alzheimer's disease	0.00095	0.00657	CcSEcCtD
Epinephrine—Psychotic disorder—Memantine—Alzheimer's disease	0.000948	0.00656	CcSEcCtD
Epinephrine—SLC22A1—forebrain—Alzheimer's disease	0.000943	0.0265	CbGeAlD
Epinephrine—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.000928	0.00642	CcSEcCtD
Epinephrine—ADRB1—forebrain—Alzheimer's disease	0.000908	0.0255	CbGeAlD
Epinephrine—Sweating increased—Donepezil—Alzheimer's disease	0.0009	0.00623	CcSEcCtD
Epinephrine—ADRBK1—brain—Alzheimer's disease	0.0009	0.0253	CbGeAlD
Epinephrine—Flushing—Galantamine—Alzheimer's disease	0.000886	0.00613	CcSEcCtD
Epinephrine—Hypokalaemia—Memantine—Alzheimer's disease	0.000884	0.00611	CcSEcCtD
Epinephrine—Dipivefrin—BCHE—Alzheimer's disease	0.000872	0.215	CrCbGaD
Epinephrine—SLC22A1—telencephalon—Alzheimer's disease	0.000867	0.0244	CbGeAlD
Epinephrine—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.000864	0.00598	CcSEcCtD
Epinephrine—Arrhythmia—Galantamine—Alzheimer's disease	0.000853	0.0059	CcSEcCtD
Epinephrine—Mental disorder—Galantamine—Alzheimer's disease	0.000836	0.00579	CcSEcCtD
Epinephrine—ADRB1—telencephalon—Alzheimer's disease	0.000835	0.0235	CbGeAlD
Epinephrine—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000834	0.00577	CcSEcCtD
Epinephrine—Sweating increased—Memantine—Alzheimer's disease	0.000817	0.00566	CcSEcCtD
Epinephrine—Tension—Galantamine—Alzheimer's disease	0.000815	0.00564	CcSEcCtD
Epinephrine—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000812	0.00562	CcSEcCtD
Epinephrine—Renal failure—Donepezil—Alzheimer's disease	0.00081	0.0056	CcSEcCtD
Epinephrine—Myocardial infarction—Donepezil—Alzheimer's disease	0.000808	0.00559	CcSEcCtD
Epinephrine—Nervousness—Galantamine—Alzheimer's disease	0.000807	0.00558	CcSEcCtD
Epinephrine—Sweating increased—Rivastigmine—Alzheimer's disease	0.0008	0.00553	CcSEcCtD
Epinephrine—Sweating—Donepezil—Alzheimer's disease	0.00079	0.00547	CcSEcCtD
Epinephrine—Agitation—Galantamine—Alzheimer's disease	0.000764	0.00528	CcSEcCtD
Epinephrine—Hyperglycaemia—Memantine—Alzheimer's disease	0.000757	0.00524	CcSEcCtD
Epinephrine—Terbutaline—BCHE—Alzheimer's disease	0.000756	0.186	CrCbGaD
Epinephrine—Haemoglobin—Donepezil—Alzheimer's disease	0.000744	0.00514	CcSEcCtD
Epinephrine—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000741	0.00512	CcSEcCtD
Epinephrine—Haemorrhage—Donepezil—Alzheimer's disease	0.00074	0.00512	CcSEcCtD
Epinephrine—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000738	0.0051	CcSEcCtD
Epinephrine—Hallucination—Donepezil—Alzheimer's disease	0.000736	0.00509	CcSEcCtD
Epinephrine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000736	0.00509	CcSEcCtD
Epinephrine—Renal failure—Memantine—Alzheimer's disease	0.000736	0.00509	CcSEcCtD
Epinephrine—Palpitations—Galantamine—Alzheimer's disease	0.000734	0.00508	CcSEcCtD
Epinephrine—Myocardial infarction—Memantine—Alzheimer's disease	0.000733	0.00507	CcSEcCtD
Epinephrine—Drowsiness—Rivastigmine—Alzheimer's disease	0.000732	0.00506	CcSEcCtD
Epinephrine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000722	0.00499	CcSEcCtD
Epinephrine—Renal failure—Rivastigmine—Alzheimer's disease	0.00072	0.00498	CcSEcCtD
Epinephrine—ADRA1A—forebrain—Alzheimer's disease	0.000718	0.0202	CbGeAlD
Epinephrine—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000718	0.00496	CcSEcCtD
Epinephrine—Hypertension—Galantamine—Alzheimer's disease	0.000717	0.00496	CcSEcCtD
Epinephrine—Chest pain—Galantamine—Alzheimer's disease	0.000707	0.00489	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000703	0.00486	CcSEcCtD
Epinephrine—Sweating—Rivastigmine—Alzheimer's disease	0.000702	0.00485	CcSEcCtD
Epinephrine—ADRA1B—nervous system—Alzheimer's disease	0.000693	0.0195	CbGeAlD
Epinephrine—ADRA1D—nervous system—Alzheimer's disease	0.000678	0.0191	CbGeAlD
Epinephrine—Haemoglobin—Memantine—Alzheimer's disease	0.000675	0.00467	CcSEcCtD
Epinephrine—Haemorrhage—Memantine—Alzheimer's disease	0.000672	0.00465	CcSEcCtD
Epinephrine—Hallucination—Memantine—Alzheimer's disease	0.000668	0.00462	CcSEcCtD
Epinephrine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000668	0.00462	CcSEcCtD
Epinephrine—ADRA1B—central nervous system—Alzheimer's disease	0.000668	0.0188	CbGeAlD
Epinephrine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000665	0.0046	CcSEcCtD
Epinephrine—Tachycardia—Galantamine—Alzheimer's disease	0.000662	0.00458	CcSEcCtD
Epinephrine—Arrhythmia—Donepezil—Alzheimer's disease	0.000661	0.00457	CcSEcCtD
Epinephrine—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00066	0.00457	CcSEcCtD
Epinephrine—ADRA1A—telencephalon—Alzheimer's disease	0.00066	0.0186	CbGeAlD
Epinephrine—Skin disorder—Galantamine—Alzheimer's disease	0.000659	0.00456	CcSEcCtD
Epinephrine—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000657	0.00455	CcSEcCtD
Epinephrine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000656	0.00454	CcSEcCtD
Epinephrine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000654	0.00452	CcSEcCtD
Epinephrine—Hallucination—Rivastigmine—Alzheimer's disease	0.000654	0.00452	CcSEcCtD
Epinephrine—ADRA1D—central nervous system—Alzheimer's disease	0.000653	0.0184	CbGeAlD
Epinephrine—Mental disorder—Donepezil—Alzheimer's disease	0.000648	0.00448	CcSEcCtD
Epinephrine—Erythema—Donepezil—Alzheimer's disease	0.000644	0.00446	CcSEcCtD
Epinephrine—Tension—Donepezil—Alzheimer's disease	0.000632	0.00437	CcSEcCtD
Epinephrine—ADRA2C—telencephalon—Alzheimer's disease	0.000629	0.0177	CbGeAlD
Epinephrine—Nervousness—Donepezil—Alzheimer's disease	0.000626	0.00433	CcSEcCtD
Epinephrine—Flushing—Memantine—Alzheimer's disease	0.000623	0.00431	CcSEcCtD
Epinephrine—Insomnia—Galantamine—Alzheimer's disease	0.000613	0.00424	CcSEcCtD
Epinephrine—Flushing—Rivastigmine—Alzheimer's disease	0.00061	0.00422	CcSEcCtD
Epinephrine—Paraesthesia—Galantamine—Alzheimer's disease	0.000609	0.00421	CcSEcCtD
Epinephrine—Somnolence—Galantamine—Alzheimer's disease	0.000603	0.00417	CcSEcCtD
Epinephrine—Arrhythmia—Memantine—Alzheimer's disease	0.0006	0.00415	CcSEcCtD
Epinephrine—Agitation—Donepezil—Alzheimer's disease	0.000592	0.00409	CcSEcCtD
Epinephrine—Mental disorder—Memantine—Alzheimer's disease	0.000589	0.00407	CcSEcCtD
Epinephrine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000587	0.00406	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000586	0.00405	CcSEcCtD
Epinephrine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000576	0.00398	CcSEcCtD
Epinephrine—Tension—Memantine—Alzheimer's disease	0.000574	0.00397	CcSEcCtD
Epinephrine—Erythema—Rivastigmine—Alzheimer's disease	0.000572	0.00396	CcSEcCtD
Epinephrine—Nervousness—Memantine—Alzheimer's disease	0.000568	0.00393	CcSEcCtD
Epinephrine—Tension—Rivastigmine—Alzheimer's disease	0.000561	0.00388	CcSEcCtD
Epinephrine—Hypertension—Donepezil—Alzheimer's disease	0.000556	0.00385	CcSEcCtD
Epinephrine—Nervousness—Rivastigmine—Alzheimer's disease	0.000556	0.00384	CcSEcCtD
Epinephrine—Chest pain—Donepezil—Alzheimer's disease	0.000548	0.00379	CcSEcCtD
Epinephrine—ADRA2A—forebrain—Alzheimer's disease	0.000546	0.0153	CbGeAlD
Epinephrine—Agitation—Memantine—Alzheimer's disease	0.000537	0.00372	CcSEcCtD
Epinephrine—ADRA1B—brain—Alzheimer's disease	0.00053	0.0149	CbGeAlD
Epinephrine—Agitation—Rivastigmine—Alzheimer's disease	0.000526	0.00364	CcSEcCtD
Epinephrine—ADRA1D—brain—Alzheimer's disease	0.000518	0.0146	CbGeAlD
Epinephrine—Palpitations—Memantine—Alzheimer's disease	0.000517	0.00357	CcSEcCtD
Epinephrine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000515	0.00357	CcSEcCtD
Epinephrine—SLC22A1—nervous system—Alzheimer's disease	0.000512	0.0144	CbGeAlD
Epinephrine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000508	0.00351	CcSEcCtD
Epinephrine—Palpitations—Rivastigmine—Alzheimer's disease	0.000506	0.0035	CcSEcCtD
Epinephrine—Hypertension—Memantine—Alzheimer's disease	0.000505	0.00349	CcSEcCtD
Epinephrine—ADRA2A—telencephalon—Alzheimer's disease	0.000502	0.0141	CbGeAlD
Epinephrine—Chest pain—Memantine—Alzheimer's disease	0.000498	0.00344	CcSEcCtD
Epinephrine—Hypertension—Rivastigmine—Alzheimer's disease	0.000494	0.00342	CcSEcCtD
Epinephrine—ADRB1—nervous system—Alzheimer's disease	0.000493	0.0139	CbGeAlD
Epinephrine—SLC22A1—central nervous system—Alzheimer's disease	0.000493	0.0139	CbGeAlD
Epinephrine—Chest pain—Rivastigmine—Alzheimer's disease	0.000487	0.00337	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000484	0.00335	CcSEcCtD
Epinephrine—Insomnia—Donepezil—Alzheimer's disease	0.000475	0.00329	CcSEcCtD
Epinephrine—ADRB1—central nervous system—Alzheimer's disease	0.000474	0.0133	CbGeAlD
Epinephrine—Paraesthesia—Donepezil—Alzheimer's disease	0.000472	0.00326	CcSEcCtD
Epinephrine—Nervous system disorder—Memantine—Alzheimer's disease	0.000468	0.00324	CcSEcCtD
Epinephrine—Somnolence—Donepezil—Alzheimer's disease	0.000467	0.00323	CcSEcCtD
Epinephrine—Tachycardia—Memantine—Alzheimer's disease	0.000466	0.00322	CcSEcCtD
Epinephrine—Skin disorder—Memantine—Alzheimer's disease	0.000464	0.00321	CcSEcCtD
Epinephrine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000461	0.00319	CcSEcCtD
Epinephrine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000458	0.00317	CcSEcCtD
Epinephrine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000456	0.00315	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000454	0.00314	CcSEcCtD
Epinephrine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000453	0.00314	CcSEcCtD
Epinephrine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000451	0.00312	CcSEcCtD
Epinephrine—Dopamine—MAOB—Alzheimer's disease	0.000449	0.111	CrCbGaD
Epinephrine—Dizziness—Galantamine—Alzheimer's disease	0.000448	0.0031	CcSEcCtD
Epinephrine—Insomnia—Memantine—Alzheimer's disease	0.000432	0.00299	CcSEcCtD
Epinephrine—Vomiting—Galantamine—Alzheimer's disease	0.000431	0.00298	CcSEcCtD
Epinephrine—Paraesthesia—Memantine—Alzheimer's disease	0.000429	0.00296	CcSEcCtD
Epinephrine—Somnolence—Memantine—Alzheimer's disease	0.000424	0.00293	CcSEcCtD
Epinephrine—Insomnia—Rivastigmine—Alzheimer's disease	0.000422	0.00292	CcSEcCtD
Epinephrine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000419	0.0029	CcSEcCtD
Epinephrine—Somnolence—Rivastigmine—Alzheimer's disease	0.000415	0.00287	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000412	0.00285	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000403	0.00279	CcSEcCtD
Epinephrine—Nausea—Galantamine—Alzheimer's disease	0.000403	0.00279	CcSEcCtD
Epinephrine—SLC22A1—brain—Alzheimer's disease	0.000391	0.011	CbGeAlD
Epinephrine—ADRA1A—nervous system—Alzheimer's disease	0.00039	0.011	CbGeAlD
Epinephrine—ADRB1—brain—Alzheimer's disease	0.000377	0.0106	CbGeAlD
Epinephrine—ADRA1A—central nervous system—Alzheimer's disease	0.000375	0.0105	CbGeAlD
Epinephrine—ADRA2C—nervous system—Alzheimer's disease	0.000371	0.0104	CbGeAlD
Epinephrine—ADRA1A—cerebellum—Alzheimer's disease	0.000367	0.0103	CbGeAlD
Epinephrine—ADRA2C—central nervous system—Alzheimer's disease	0.000357	0.01	CbGeAlD
Epinephrine—ADRA2C—cerebellum—Alzheimer's disease	0.000349	0.00982	CbGeAlD
Epinephrine—Dizziness—Donepezil—Alzheimer's disease	0.000348	0.0024	CcSEcCtD
Epinephrine—SLC22A5—cerebellum—Alzheimer's disease	0.000335	0.00941	CbGeAlD
Epinephrine—Vomiting—Donepezil—Alzheimer's disease	0.000334	0.00231	CcSEcCtD
Epinephrine—Dizziness—Memantine—Alzheimer's disease	0.000316	0.00218	CcSEcCtD
Epinephrine—Nausea—Donepezil—Alzheimer's disease	0.000312	0.00216	CcSEcCtD
Epinephrine—Dizziness—Rivastigmine—Alzheimer's disease	0.000309	0.00214	CcSEcCtD
Epinephrine—Vomiting—Memantine—Alzheimer's disease	0.000303	0.0021	CcSEcCtD
Epinephrine—ADRA1A—brain—Alzheimer's disease	0.000298	0.00837	CbGeAlD
Epinephrine—Vomiting—Rivastigmine—Alzheimer's disease	0.000297	0.00205	CcSEcCtD
Epinephrine—ADRA2A—nervous system—Alzheimer's disease	0.000296	0.00833	CbGeAlD
Epinephrine—ADRA2A—central nervous system—Alzheimer's disease	0.000285	0.00802	CbGeAlD
Epinephrine—ADRA2C—brain—Alzheimer's disease	0.000284	0.00798	CbGeAlD
Epinephrine—Nausea—Memantine—Alzheimer's disease	0.000283	0.00196	CcSEcCtD
Epinephrine—ADRA2A—cerebellum—Alzheimer's disease	0.000279	0.00784	CbGeAlD
Epinephrine—Nausea—Rivastigmine—Alzheimer's disease	0.000277	0.00192	CcSEcCtD
Epinephrine—SLC22A5—brain—Alzheimer's disease	0.000272	0.00764	CbGeAlD
Epinephrine—CYP3A4—nervous system—Alzheimer's disease	0.000233	0.00656	CbGeAlD
Epinephrine—ADRA2A—brain—Alzheimer's disease	0.000226	0.00637	CbGeAlD
Epinephrine—CYP3A4—central nervous system—Alzheimer's disease	0.000224	0.00631	CbGeAlD
Epinephrine—Dopamine—SLC6A4—Alzheimer's disease	0.000203	0.05	CrCbGaD
Epinephrine—L-DOPA—CYP2D6—Alzheimer's disease	0.000154	0.0378	CrCbGaD
Epinephrine—Dopamine—CYP2D6—Alzheimer's disease	0.000143	0.0352	CrCbGaD
Epinephrine—ADRA2C—Signaling Pathways—APOE—Alzheimer's disease	4.94e-06	3.41e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PPARG—Alzheimer's disease	4.93e-06	3.41e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.93e-06	3.4e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—F2—Alzheimer's disease	4.93e-06	3.4e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CCL2—Alzheimer's disease	4.93e-06	3.4e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CAV1—Alzheimer's disease	4.9e-06	3.38e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NOTCH1—Alzheimer's disease	4.88e-06	3.37e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NGF—Alzheimer's disease	4.88e-06	3.37e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CALM1—Alzheimer's disease	4.88e-06	3.37e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	4.86e-06	3.36e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—APOE—Alzheimer's disease	4.86e-06	3.36e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—LEP—Alzheimer's disease	4.86e-06	3.36e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—VEGFA—Alzheimer's disease	4.86e-06	3.35e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IGF1—Alzheimer's disease	4.84e-06	3.34e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—INS—Alzheimer's disease	4.84e-06	3.34e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—TP53—Alzheimer's disease	4.83e-06	3.33e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	4.83e-06	3.33e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	4.82e-06	3.33e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CAV1—Alzheimer's disease	4.82e-06	3.33e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—CALM1—Alzheimer's disease	4.82e-06	3.33e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—APOE—Alzheimer's disease	4.8e-06	3.31e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	4.79e-06	3.31e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.77e-06	3.29e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—CAV1—Alzheimer's disease	4.76e-06	3.28e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCR5—Alzheimer's disease	4.75e-06	3.28e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	4.75e-06	3.28e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ENO1—Alzheimer's disease	4.74e-06	3.27e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	4.74e-06	3.27e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—ESR1—Alzheimer's disease	4.72e-06	3.26e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	4.72e-06	3.25e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—F2—Alzheimer's disease	4.66e-06	3.22e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	4.66e-06	3.21e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—HTR2A—Alzheimer's disease	4.65e-06	3.21e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	4.65e-06	3.21e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	4.65e-06	3.21e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—ESR1—Alzheimer's disease	4.64e-06	3.21e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	4.62e-06	3.19e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	4.59e-06	3.17e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—F2—Alzheimer's disease	4.59e-06	3.17e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—GSK3B—Alzheimer's disease	4.58e-06	3.16e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TP53—Alzheimer's disease	4.57e-06	3.15e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—INS—Alzheimer's disease	4.56e-06	3.15e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NOTCH1—Alzheimer's disease	4.56e-06	3.15e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—NOS3—Alzheimer's disease	4.55e-06	3.14e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CREB1—Alzheimer's disease	4.55e-06	3.14e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	4.54e-06	3.13e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	4.52e-06	3.12e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—INS—Alzheimer's disease	4.52e-06	3.12e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NOTCH1—Alzheimer's disease	4.49e-06	3.1e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	4.49e-06	3.1e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	4.49e-06	3.1e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—A2M—Alzheimer's disease	4.49e-06	3.1e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—INS—Alzheimer's disease	4.46e-06	3.08e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TGFB1—Alzheimer's disease	4.46e-06	3.08e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCL2—Alzheimer's disease	4.45e-06	3.07e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—NOS3—Alzheimer's disease	4.43e-06	3.06e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	4.41e-06	3.05e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	4.41e-06	3.05e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—BCHE—Alzheimer's disease	4.41e-06	3.04e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NOS3—Alzheimer's disease	4.39e-06	3.03e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	4.39e-06	3.03e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IGF1—Alzheimer's disease	4.37e-06	3.02e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	4.34e-06	2.99e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	4.32e-06	2.98e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	4.32e-06	2.98e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	4.32e-06	2.98e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	4.32e-06	2.98e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	4.28e-06	2.95e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—GSK3B—Alzheimer's disease	4.28e-06	2.95e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CREB1—Alzheimer's disease	4.25e-06	2.93e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—NOS3—Alzheimer's disease	4.24e-06	2.93e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—INS—Alzheimer's disease	4.22e-06	2.91e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—GSK3B—Alzheimer's disease	4.21e-06	2.91e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—IL6—Alzheimer's disease	4.18e-06	2.89e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PPARG—Alzheimer's disease	4.18e-06	2.89e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CREB1—Alzheimer's disease	4.18e-06	2.88e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PTGS2—Alzheimer's disease	4.16e-06	2.87e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	4.16e-06	2.87e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—INS—Alzheimer's disease	4.16e-06	2.87e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCL2—Alzheimer's disease	4.15e-06	2.87e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	4.13e-06	2.85e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—INS—Alzheimer's disease	4.1e-06	2.83e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCL2—Alzheimer's disease	4.09e-06	2.82e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IGF1—Alzheimer's disease	4.08e-06	2.82e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	4.08e-06	2.81e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.08e-06	2.81e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	4.07e-06	2.81e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	4.06e-06	2.8e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PTGS2—Alzheimer's disease	4.05e-06	2.8e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	4.05e-06	2.79e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	4.03e-06	2.78e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	4.03e-06	2.78e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	4.02e-06	2.77e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	4.01e-06	2.77e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	4.01e-06	2.77e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	4e-06	2.76e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.99e-06	2.75e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	3.98e-06	2.75e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NOS3—Alzheimer's disease	3.96e-06	2.74e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	3.91e-06	2.7e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	3.9e-06	2.69e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PTGS2—Alzheimer's disease	3.88e-06	2.68e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—AKT1—Alzheimer's disease	3.86e-06	2.66e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	3.86e-06	2.66e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	3.83e-06	2.65e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	3.79e-06	2.61e-05	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—AKT1—Alzheimer's disease	3.76e-06	2.6e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	3.74e-06	2.58e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CASP3—Alzheimer's disease	3.73e-06	2.57e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	3.71e-06	2.56e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.71e-06	2.56e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL6—Alzheimer's disease	3.7e-06	2.56e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	3.7e-06	2.56e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—LPL—Alzheimer's disease	3.7e-06	2.55e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	3.69e-06	2.55e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TP53—Alzheimer's disease	3.67e-06	2.53e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	3.66e-06	2.52e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	3.66e-06	2.52e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	3.64e-06	2.52e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	3.63e-06	2.51e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—NOS3—Alzheimer's disease	3.6e-06	2.48e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	3.59e-06	2.48e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	3.57e-06	2.46e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	3.48e-06	2.4e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	3.47e-06	2.4e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	3.46e-06	2.39e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	3.45e-06	2.38e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	3.43e-06	2.37e-05	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.43e-06	2.37e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MAPK8—Alzheimer's disease	3.43e-06	2.36e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—AKT1—Alzheimer's disease	3.42e-06	2.36e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.4e-06	2.35e-05	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	3.4e-06	2.34e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	3.4e-06	2.34e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	3.37e-06	2.33e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	3.37e-06	2.33e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	3.37e-06	2.32e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL6—Alzheimer's disease	3.36e-06	2.32e-05	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	3.35e-06	2.31e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	3.34e-06	2.31e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	3.33e-06	2.3e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	3.32e-06	2.29e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	3.32e-06	2.29e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	3.3e-06	2.28e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	3.29e-06	2.27e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	3.24e-06	2.23e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.21e-06	2.21e-05	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	3.17e-06	2.19e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—VEGFA—Alzheimer's disease	3.16e-06	2.18e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—LPL—Alzheimer's disease	3.16e-06	2.18e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	3.14e-06	2.17e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	3.12e-06	2.16e-05	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	3.12e-06	2.16e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	3.12e-06	2.15e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	3.11e-06	2.15e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	3.11e-06	2.15e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.11e-06	2.15e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—APOE—Alzheimer's disease	3.1e-06	2.14e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—AKT1—Alzheimer's disease	3.1e-06	2.14e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	3.09e-06	2.14e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	3.09e-06	2.13e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	3.08e-06	2.13e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	3.07e-06	2.12e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	3.07e-06	2.12e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	3.05e-06	2.11e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	3.05e-06	2.1e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	3.01e-06	2.08e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TGFB1—Alzheimer's disease	2.9e-06	2e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	2.89e-06	1.99e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	2.88e-06	1.99e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	2.88e-06	1.99e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	2.86e-06	1.97e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	2.85e-06	1.96e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	2.84e-06	1.96e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	2.84e-06	1.96e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	2.82e-06	1.95e-05	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.77e-06	1.91e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	2.75e-06	1.9e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	2.73e-06	1.88e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	2.7e-06	1.86e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.68e-06	1.85e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.67e-06	1.84e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	2.67e-06	1.84e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	2.66e-06	1.84e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—APOE—Alzheimer's disease	2.65e-06	1.83e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—INS—Alzheimer's disease	2.65e-06	1.83e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	2.65e-06	1.83e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	2.63e-06	1.81e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	2.63e-06	1.81e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	2.62e-06	1.81e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	2.59e-06	1.79e-05	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.58e-06	1.78e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	2.55e-06	1.76e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	2.54e-06	1.75e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	2.53e-06	1.74e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	2.52e-06	1.74e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	2.45e-06	1.69e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.44e-06	1.68e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	2.41e-06	1.66e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TP53—Alzheimer's disease	2.39e-06	1.65e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	2.35e-06	1.62e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	2.34e-06	1.62e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	2.33e-06	1.61e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	2.32e-06	1.6e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	2.31e-06	1.59e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—INS—Alzheimer's disease	2.26e-06	1.56e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.2e-06	1.52e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL6—Alzheimer's disease	2.19e-06	1.51e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	2.18e-06	1.5e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	2.17e-06	1.5e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	2.16e-06	1.49e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	2.14e-06	1.48e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	2.13e-06	1.47e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	2.13e-06	1.47e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—AKT1—Alzheimer's disease	2.09e-06	1.44e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.05e-06	1.42e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.05e-06	1.41e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—AKT1—Alzheimer's disease	2.04e-06	1.4e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.03e-06	1.4e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—AKT1—Alzheimer's disease	2.02e-06	1.39e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	2.02e-06	1.39e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	1.99e-06	1.38e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.99e-06	1.37e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.99e-06	1.37e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	1.98e-06	1.37e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	1.98e-06	1.36e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—AKT1—Alzheimer's disease	1.95e-06	1.35e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	1.95e-06	1.35e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	1.85e-06	1.27e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	1.84e-06	1.27e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	1.82e-06	1.26e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.82e-06	1.25e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	1.82e-06	1.25e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	1.8e-06	1.24e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.78e-06	1.23e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	1.76e-06	1.22e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—INS—Alzheimer's disease	1.75e-06	1.21e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	1.7e-06	1.17e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	1.68e-06	1.16e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	1.65e-06	1.14e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	1.64e-06	1.13e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	1.61e-06	1.11e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.53e-06	1.06e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	1.5e-06	1.03e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	1.49e-06	1.03e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.4e-06	9.67e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	1.38e-06	9.54e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.07e-06	7.37e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	9.13e-07	6.3e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	7.04e-07	4.86e-06	CbGpPWpGaD
